Patent · US Active

Mammalian cells and methods for engineering the same

US12241062B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2023
Grant dateMar 4, 2025
Priority date
Expiry dateOct 23, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14152
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides mammalian cell lines for expression of viral vectors, and methods of making and using the same. Provided methods employ use of identifiers that are capable of being packaged into a viral vector to select and/or identify mammalian cell lines with engineered sequences associated with beneficial characteristics for viral vectors production. Exemplary viral vectors include AAV vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.